Latest
Sources
Trade Ideas
Speakers
Sign in
Go
Hims & Hers Health (HIMS) Is Down 29.2% After Semaglutide Lawsuit And DOJ Referral - Has The Bull Case Changed?
Original source ↗
| February 14, 2026 at 00:26 UTC |
Finnhub - HIMS
No analysis available.
Trade Ideas
Ticker
Direction
Speaker
Thesis
Time
HIMS
NONE
Finnhub News
—
—